Product Description
The global spine endoscope market was valued at $272 million in 2024. This is expected to increase over the forecast period at a CAGR of 10.4% to reach over $544 million.
The full report suite on the global market for spine endoscopes includes market analysis complete with units sold, ASP and market value.
MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2024
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL SPINE ENDOSCOPE MARKET TRENDS
A key driver of this market is the time efficiency associated with the use of endoscopes in spine procedures. From a clinical and business perspective, more surgeons are turning to minimally invasive approaches to enhance the competitiveness of their practice and potentially increase revenue. These procedures typically require less intraoperative and hospital time, allowing surgeons to perform more cases within the same timeframe compared to traditional open surgeries.
GLOBAL SPINE ENDOSCOPE MARKET SHARE INSIGHTS
- Joimax was the leading competitor in the global spine endoscope market in 2024. Joimax was the leader of the market in North America, Western Europe and the Rest of the World by a large margin. The main products of Joimax are TESSYS®, iLESSYS® and CESSYS®.
- Richard Wolf was the second-leading competitor in the global spine endoscope market. This German-based company ranked second in all individual regions reported as well. Richard Wolf’s main product in the spine endoscope market is Vertebris®.
- Shanghai Kinetic was the third-leading competitor in the global spine endoscope market in 2024. This company held the third-largest share in the North American and Rest of World segments of the competitive market.
RESEARCH SCOPE SUMMARY
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Baltic States, Bulgaria, Kazakhstan, Poland, Romania, Croatia, Czech Republic, Russia, Greece, Turkey, Hungary, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2023 |
| Forecast Period | 2025-2031 |
| Historical Data | 2021-2023 |
| Quantitative Data | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Data | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
